African American patients with chronic obstructive pulmonary disease, or COPD, are less likely to participate in pulmonary rehabilitation programs than white patients, even when there are programs nearby,
ISPOR, the professional society for health economics and outcomes research (HEOR), examined the past 20 years of scientific publications in HEOR this afternoon at its ISPOR 2019 annual conference with the spotlight session issue panel [SP2], “Back to the Future in Value in Health.”
ISPOR, the professional society for health economics and outcomes research (HEOR), explored the issue of orphan drug approvals and how they challenge health plans at its ISPOR 2019 annual conference this morning.
Current or former smokers with severe limitation in lung function are more likely to die from respiratory-related causes, while deaths from heart disease and lung cancer are more common in smokers with milder limitation in lung function
Patients given opioids in the intensive care unit do not appear to be at higher risk of receiving opioid prescriptions once they leave the hospital, according to research presented at ATS 2019.
Do family members of loved ones who are critically ill and being treated in an intensive care unit at a hospital belong there when clinicians are performing bedside procedures? New study finds many critical care clinicians have conflicting feelings about the practice.
Are electronic health records and computer calculations a better, more accurate way to predict clinical outcomes for patients with chronic obstructive pulmonary disease? According to the results of a new study by researchers at Intermountain Healthcare in Salt Lake City, the answer is yes.
ISPOR, the professional society for health economics and outcomes research (HEOR), opened its ISPOR 2019 annual conference this morning with a keynote and first plenary, “The Dawn of Disruption in the Health Sector: Will Innovative Technologies Require Innovative Thinking?”
In a Phase 2 trial, RTB101, which belongs to a class of drugs known as TORC1 inhibitors, was observed to be well tolerated and to reduce the incidence of respiratory tract infections in adults age 65 and older when given once daily for 16 weeks during winter cold and flu season
Black lung disease and other non-malignant respiratory diseases appear to account for a greater proportion of deaths in younger generations of coal miners than in older generations of miners, according to research presented at ATS 2019.
Progressive massive fibrosis (PMF), the worst form of black lung disease, is rising among coal miners, but the reasons for this trend remain unclear, according to research presented at ATS 2019.
Patients with severe eosinophilic asthma, who participated in three different Phase 3 trials of benralizumab (brand name Fasenra) and then enrolled in a long-term trial of the drug’s efficacy and safety, continued to experience fewer exacerbations and improved pulmonary function and quality of life
An enzyme called diacylglycerol kinase zeta (DGKζ) appears to play an important role in suppressing runaway inflammation in asthma and may represent a novel therapeutic target,
Patients at greatest risk of dying from pulmonary arterial hypertension (PAH) may be identified through cardiac magnetic resonance imaging (MRI) and the information the noninvasive scan provides about the functional level of the heart’s right ventricle, according to research presented at ATS 2019.
ISPOR—the professional society for health economics and outcomes research (HEOR)—honored global leaders in the field at its Annual Awards Banquet last night.
In addition to suppressing tumors, the protein tuberous sclerosis complex 2 (TSC2) may play a role in preventing or treating pulmonary arterial hypertension (PAH), according to research presented at ATS 2019.
Reversibly paralyzing and heavily sedating hospitalized patients with severe breathing problems do not improve outcomes in most cases, according to a clinical trial conducted at dozens of North American hospitals. The trial settles a long-standing debate in the critical care medicine community.
A study of more than 17,000 patients finds a new laboratory-based method of estimating outcomes for patients with COPD may help physicians better provide proper care, referrals, and services for these patients at the end of life.
Much like cancer, sepsis isn’t simply one condition, but rather many conditions with varying clinical characteristics that could benefit from different treatments, according to a study involving more than 100,000 patients. The findings could explain why several recent clinical trials have failed.
Bacterial pneumonia appears to be linked to ongoing breathing problems in previously healthy infants who were hospitalized in a pediatric intensive care unit for acute respiratory failure, according to research presented at ATS 2019.
More than one million stem cell treatments have been conducted in the United States during the past ten years. Physicians and other healthcare providers are beginning to realize regenerative medicine is the future of medicine; however major health issues remain unanswered. Dr. Nathan Bryan, one the country’s leading experts in the mechanism of nitric oxide, will tell more than seven thousand physicians attending the 27th Annual Spring Conference of the American Academy of Anti-Aging Medicine on Saturday that “the ability to use our own cells to heal our own body make good medical sense.
Current treatments of Type 2 diabetes can help the body use insulin at various stages of the disease, but they can also be expensive and subject patients to lifelong medication regimens and side effects. Thanks to new therapeutic ultrasound technology, one promising alternative looks to reshape how early Type 2 diabetes is managed. A group of researchers has used ultrasound therapy to stimulate insulin release from mice on demand. The team will present their findings at the 177th ASA Meeting, May 13-17.
Dana-Farber Cancer Institute researchers are presenting more than 70 research studies at the 2019 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, May 31st- June 4th. ASCO is the world’s largest clinical cancer research meeting, attracting more than 30,000 oncology professionals from around the world.
Blood tests that track the amount of tumor DNA can ― after only one month of drug therapy ― detect how well treatment is working in patients with skin cancer, a new study finds.
Michigan Medicine experts highlighted new research during the keynote address and plenary session at the annual Society for Academic Emergency Medicine Annual Meeting.
Penn study shows users who score high on a depression and anxiety survey often post photos that are less aesthetically appealing, less vivid in color or display little depth of field.
Journalists and bloggers are invited to join top scientists and practitioners as they discuss new nutrition research findings during Nutrition 2019, the flagship meeting of the American Society for Nutrition.
ISPOR—the professional society for health economics and outcomes research (HEOR)—released the final program and speakers for its upcoming ISPOR 2019 annual conference scheduled for May 18-22, 2019 in New Orleans, LA, USA.
Uma mastectomia menos invasiva que deixa a superfície da mama intacta se tornou uma opção mais segura para pacientes, incluindo aquelas em que o câncer de mama espalhou para os ganglios linfáticos próximos ou aquelas que têm fatores de risco para complicação cirúrgicas, mostra o estudo da Mayo Clinic.
Teens who experience cyberbullying are more likely to suffer from poor sleep, which in turn raises levels of depression, found a University at Buffalo study.
A new clinical trial finds transcatheter aortic valve replacement (TAVR) to be equivalent or potentially preferable to surgical aortic valve replacement (SAVR) for low risk patients.
A new nomogram for assessing metastatic risk in esophageal cancer patients shows promise for more accurate risk-stratification, which is particularly relevant for stage T2 patients.
In a large international clinical study presented at the 99th Annual Meeting of the American Association for Thoracic Surgery, Dr. Moishe Liberman and his team showed that thoracoscopic lobectomy—video-assisted thoracoscopic surgery (VATS)—combined with pulmonary artery sealing using an ultrasonic energy device reduced the risk of post-operative bleeding, complications and pain.
According to a new study, an ultrasonic vessel-sealing device can improve patient outcomes by reducing the incidence of thoracotomy conversion for VATS/robotic anatomical lung resection
Investigators at Rutgers Cancer Institute of New Jersey have found that approximately 30 percent of men with localized prostate cancer may have alterations in DNA damage response pathways.
The results of a joint study between University of Utah Health and Intermountain Healthcare show inducing labor one week early costs the same as waiting for spontaneous labor.
The drug eculizumab, a synthetic antibody that inhibits the inflammatory response, significantly reduced the risk of relapse with neuromyelitis optica spectrum disorder (NMOSD). Mayo Clinic researchers and international collaborators published their findings in the New England Journal of Medicine.
A study of a blood pressure drug does not show any benefit for people with Parkinson’s disease, according to findings released today that will be presented at the American Academy of Neurology’s 71st Annual Meeting in Philadelphia, May 4 to 10, 2019. The drug isradipine had shown promise in small, early studies and hopes were high that this could be the first drug to slow the progression of the disease.
More Americans are being diagnosed with eye complications of shingles, but older adults can call the shots on whether they develop the painful rash that can cost them their eyesight.
The American Association for Thoracic Surgery 99th Annual Meeting takes place at the Metro Toronto Convention Center, Toronto, Canada, May 4 - 7, 2019.
An early stage trial of an investigational therapy for amyotrophic lateral sclerosis (ALS) suggests that people could tolerate the experimental drug and, in exploratory results, the experimental drug was linked to possible slower progression in people with a genetic form of the disease caused by mutations in a gene called superoxide dismutase 1 (SOD1). The preliminary study released today will be presented at the American Academy of Neurology’s 71st Annual Meeting in Philadelphia, May 4 to 10, 2019.
Two researchers from Children’s Hospital of Philadelphia (CHOP) were among five international experts selected to present the results of two innovative studies shaping the field of autism research at the 2019 annual meeting of the International Society for Autism Research (INSAR), held this year in Montreal, on May 1-4.
Taking a pharmaceutical formulation of cannabidiol, a cannabis-based medicine, cut seizures nearly in half for children with a rare and severe type of epilepsy called Dravet syndrome, according to a phase 3 study released today that will be presented at the American Academy of Neurology’s 71st Annual Meeting in Philadelphia, May 4 to 10, 2019. Dravet syndrome, which starts in infancy, can lead to intellectual disability and frequent, prolonged seizures. Cannabidiol is derived from marijuana that does not include the psychoactive part of the plant that creates a “high.”
Gain story ideas and learn about cutting-edge science at ACSM's comprehensive sports medicine and exercise science conference that covers the science, practice, public health and policy aspects of sports medicine, exercise science and physical activity.
Scientists and patients from all over the world are gathering in Vancouver, Canada, on Friday and Saturday to discuss new discoveries and future direction in the treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN), a drug-induced disease that has a mortality of up to 50%.
Three faculty from the Johns Hopkins School of Nursing (JHSON) have been selected for induction as Fellows of the American Association of Nurse Practitioners (FAANP). Jason Farley, Kimberly McIltrot, and Vinciya Pandian were chosen for their contributions to health care practice, research, education, and policy.“These faculty model what it means to be nurse practitioners—exceptional leaders, advanced critical thinkers, and innovators serving individuals and entire populations,” says Patricia Davidson, PhD, MEd, RN, FAAN, dean of the school.